skip to content
Dovepress - Open Access to Scientific and Medical Research
View our mobile site

8852

Sodium nitroprusside-associated cyanide toxicity in adult patients – fact or fiction? A critical review of the evidence and clinical relevance

Review

(1431) Views  (621) Full article downloads

Authors: Alissa Lockwood, John Patka, Marina Rabinovich, et al.

Published Date September 2010 Volume 2010:2 Pages 133 - 148
DOI: http://dx.doi.org/10.2147/OAJCT.S7573

Alissa Lockwood1, John Patka2, Marina Rabinovich2, Katleen Wyatt2, Prasad Abraham2

1Department of Pharmacy, Parkland Health System, Dallas, TX, USA; 2Department of Pharmacy and Drug Information, Grady Health System, Atlanta, GA, USA

Abstract: Since its US Food and Drug Administration (FDA) approval in 1974, sodium nitroprusside (SNP) has been fraught with controversy in regards to its safety. Over the years, a growing concern related to SNPs propensity to cause cyanide (CN) toxicity culminated into a series of case reports that led the FDA to develop a black-box warning with dose limitations of <2 µg/kg/min. These recommendations stemmed also from the reality of the difficulty of obtaining CN levels in a timely manner, as well as the presumed poor correlation of metabolic markers (lactate levels and pH) as it related to the severity of CN toxicity. All these issues have driven practitioners to the use of alternative agents. In this paper, we critically review the cases and the data that led to the development of these restrictive dosing recommendations and reveal several limitations of the data and assumptions that led to these recommendations. We conclude that SNP is still a reasonable agent to use in the management of patients with hypertension today and can safely be used beyond doses of 2 µg/kg/min. Furthermore, in lieu of CN levels, monitoring of lactic acid levels is also a reasonable measure to ensure safety.

Keywords: dose limits, monitoring, controversy, thiosulfate stores, cyanide levels






Readers of this article also read:

Role of aliskiren in cardio-renal protection and use in hypertensives with multiple risk factors
Nonsurgical treatment of hemifacial microsomia by therapeutic ultrasound and hybrid functional appliance
Time will tell: community acceptability of HIV vaccine research before and after the “Step Study” vaccine discontinuation
Examining the readability of patient-informed consent forms
Erratum - Intracellular heavy metal nanoparticle storage
Editorial
Perception of risk and benefit in patient-centered communication and care
The relationship between deliberate self-harm behavior, body dissatisfaction, and suicide in adolescents: current concepts
Zinc oxide nanoparticles as selective killers of proliferating cells
Cumulative clinical experience from over a decade of use of levofloxacin in community-acquired pneumonia: critical appraisal and role in therapy
  • Testimonials

    "... I was impressed at the rapidity of publication from submission to final acceptance." Dr Edwin Thrower, PhD, Yale University